Price as of · delayed, not real-time
Specializing in advanced radiation therapy systems for cancer treatment, this medical technology firm develops MRI-guided radiation therapy platforms. Investors monitor its niche position in precision oncology solutions amid ongoing financial challenges.
1 member of Congress has disclosed 2 trades in ViewRay, Inc. (VRAY), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-06-26 | PETER WELCH | sell | $1K – $15K |
| 2018-04-19 | PETER WELCH | buy | $1K – $15K |